$124.51
3.21% (Daily)
Market Cap
$12.46B
Revenue
$2.86B
Rank by MCap
#673
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Kyle W. Gano Ph.D.
Headquarters
San Diego, CA
Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally.
Loading chart…